CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2025	Jul. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (584,252)	$ (435,863)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation	89	3,436
Amortization of debt discount	192,792	14,990
Warrants granted for services	17,857
Financing fees	100,312	79,316
Loss on impairment of assets		22,340
Loss on extinguishment of debt		123,653
Amortization of right of use asset	491
Changes in operating assets and liabilities:
(Increase) decrease in security deposits	(4,900)
Increase (decrease) in accounts receivable		(67,467)
(Increase) decrease in prepaid expenses	1,542	17,287
Increase (decrease) in accounts payable	10,082	7,051
Increase (decrease) in accrued interest payable	34,900	(17,848)
Increase (decrease) in related party advances	(17,272)	89,556
Net cash used in operating activities	(248,359)	(163,549)
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures for leasehold improvements	(6,500)
Net cash used in investing activities	(6,500)
CASH FLOWS FROM FINANCING ACTIVITIES
Cash proceeds from sale of common stock	12,500	81,000
Proceeds from convertible notes payable	192,000	225,000
Proceeds from short-term loans	38,800	788
Proceeds from exercise of warrants	45,357
Payments of short-term loans		(62,500)
Payments of related party loans	(21,000)	(74,000)
Net cash provided by financing activities	267,657	170,288
Net change increase in cash	12,798	6,739
Cash - beginning of the period	11,812
Cash - end of the period	24,610	6,739
Supplemental disclosures of cash flows
Cash paid for interest
Cash paid for income taxes
Supplemental disclosures of non-cash investing and financing activities:
Common stock issued as satisfaction for contingent liability		173,653
Warrants issued with convertible notes	64,962	100,978
Warrants issued with the sale of common stock		10,500
Conversion of notes payable & accrued interest	62,180	236,000
Common stock issued as commitment fees	$ 82,229